Metformin enhances the survival ability of ovarian granulosa cells in polycystic ovary syndrome by promoting LINC00548 to suppress androgen receptor /klotho pathway
Journal of Obstetrics and Gynaecology Research · 2024
DOI: 10.1111/jog.16060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2024. Verfasst von Guangxin Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan,…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Granulosa Cells, Receptors, Androgen, Metformin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: the Hospital fund project of The Central Hospital of Wuhan.
Abstract (Originalsprache)
Background
Metformin (Met) has been reported to play the key role in the pathogenesis of polycystic ovary syndrome (PCOS). However, the precise mechanisms underlying the actions of Met in PCOS remain incompletely understood. This study aimed to confirm the mechanism of Met interacting with a long non‐coding RNA LINC00548 in PCOS.
Methods
Ovarian granulosa cells (OGCs) were incubated 500 nM dihydrotestosterone (DHT) to construct PCOS in vitro model and then were treated 20 μM Met. A series of cell experiments including Cell Counting Kit‐8, Terminal uridine nucleotide end labeling, and flow cytometry were performed to confirm the changes of OGC survival ability. Quantitative real‐time polymerase chain reaction was conducted to determine the levels of LINC00548, whereas Western blotting was applied to determine the levels of androgen receptor (AR) and klotho.
Results
Met improved the cell viability and suppressed cell apoptosis in DHT‐treated OGCs. LINC00548 downregulated in DHT‐treated OGCs was upregulated by Met, and its overexpression further enhanced the positive effects of Met on the survival ability of DHT‐treated OGCs. In addition, Met could induce the upregulation of LINC00548 to suppress the activation of AR/klotho pathway in DHT‐treated OGCs.
Conclusion
Overall, this study discovers that Met enhances the survival ability of OGCs in PCOS by elevating LINC00548 expression to suppress AR/klotho pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Gang Lei
Förderung
- the Hospital fund project of The Central Hospital of Wuhan
Zitieren
APA
Pan, G., Li, S., Xiong, G., Zhang, P., Zhang, L., Yao, Y., & Lei, G. (2024). Metformin enhances the survival ability of ovarian granulosa cells in polycystic ovary syndrome by promoting LINC00548 to suppress androgen receptor /klotho pathway. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16060
Vancouver
Pan G, Li S, Xiong G, Zhang P, Zhang L, Yao Y, et al. Metformin enhances the survival ability of ovarian granulosa cells in polycystic ovary syndrome by promoting LINC00548 to suppress androgen receptor /klotho pathway. Journal of Obstetrics and Gynaecology Research. 2024. doi:10.1111/jog.16060
BibTeX
@article{Pan2024,
author = {Pan, Guangxin and Li, Sha and Xiong, Guoping and Zhang, Pei and Zhang, Li and Yao, Yanru and Lei, Gang},
title = {Metformin enhances the survival ability of ovarian granulosa cells in polycystic ovary syndrome by promoting LINC00548 to suppress androgen receptor /klotho pathway},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2024},
doi = {10.1111/jog.16060}
}
EUVIMED